Dianne Angus

Cyclopharm Limited | Non-Executive Director

Ms Angus has executive managerial and company director experience in the biotechnology, biopharmaceutical, medical device, agritech and healthcare industries. She has long been involved in path to market asset development and commercialization in these industries, notably including the clinical validation of therapeutics to create asset and company valuation uplift. Ms Angus has expertise in corporate strategy, stakeholder and investor engagement and innovative product development. In addition, she has experience in both governance and compliance in listed capital markets. She is a member of the Risk Committee.

Companies and Roles

Company	Title	Tenure	Since
CYC Cyclopharm Limited	Non-Executive Director	4yrs, 11mth	Aug 2021
NEU Neuren Pharmaceuticals Limited	Non-Executive Director	8yrs	Jul 2018

Holdings

Company	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
NEU Neuren Pharmaceuticals Limited	16/03/26	30,000	N/A	N/A	N/A
CYC Cyclopharm Limited	12/03/26	43,375	N/A	N/A	N/A
AGN	30/06/25	N/A	N/A	500,000	N/A
IBX	21/04/23	323,375	N/A	500,000	N/A

Transactions

Company	Date	Type	Amount	Price	Value	Notes
CYC Cyclopharm Limited	12/03/26	Buy	21,052	$0.950	$19,999	Participation in share purchase plan
AGN	14/08/24	Issued	500,000	$0.275	$137,727	Issue of options
CYC Cyclopharm Limited	28/06/24	Issued	12,323	$1.420	$17,500	Participation in share purchase plan
IBX	21/04/23	Issued	30,375	$0.017	$516	Rights issue
IBX	21/04/23	Issued	50,000	$0.017	$850	As advised by the company

Any feedback about this profile? Contact Us

Build your watchlist

Already have account? Log in